Search
Searching Content indexed under Product Liability & Safety by Fletcher Moore ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Class Actions Against Pharmaceutical Companies Over Off-Label Marketing Claims Have No Leg To Stand On, Third Circuit Rules
In a recent decision of first impression in the U.S. Court of Appeals for the Third Circuit, the court in In re: Schering-Plough Corp. held that two groups of plaintiffs lacked standing to pursue claims against pharmaceutical manufacturer Schering-Plough Corporation and its affiliated marketing and sales companies for marketing drugs for off-label uses.
United States
1 Jun 2012
2
Supreme Court Orders Ninth Circuit To Revisit Preemption Ruling Against Generic OTC Ibuprofen Manufacturer
During its October 28, 2011, conference, the U.S. Supreme Court remanded to the Ninth Circuit its ruling denying federal preemption to a generic manufacturer of ibuprofen to be reassessed in light of the Court's Mensing decision last term.
United States
7 Nov 2011
3
Big Win For Drug Companies Under The New Jersey Product Liability Act
On September 29, 2011, in Bailey v. Wyeth, et al., a New Jersey appellate court affirmed summary judgment in favor of two Pfizer subsidiaries and Wyeth, Inc., dismissing claims for violations of New Jersey's Product Liability Act (PLA).
United States
10 Oct 2011
4
Pennsylvania District Court Dismisses Class Action Against Pharmaceutical Giant Johnson and Johnson
Judge Mary McLaughlin of the U.S. District Court for the Eastern District of Pennsylvania tossed a class action lawsuit last week after finding that the named plaintiffs lacked standing in "In re McNeil Consumer Healthcare Litigation".
United States
27 Sep 2011
5
Pennsylvania District Court Dismisses Class Action Against Pharmaceutical Giant Johnson & Johnson
Judge Mary McLaughlin of the U.S. District Court for the Eastern District of Pennsylvania tossed a class action lawsuit last week after finding that the named plaintiffs lacked standing in In re McNeil Consumer Healthcare Litigation.
United States
28 Jul 2011
6
In Pennsylvania Products Liability Decisions, Pharmaceutical Manufacturers May Lose a Little, but Gain a Lot
In a trio of recent Pennsylvania Superior Court decisions involving the diet drug Redux, plaintiffs' lawyers may have gained a new cause of action against pharmaceutical manufacturers, but not before the reaffirmance of the learned intermediary defense and the rejection of a plaintiff's unique challenge to that defense.
United States
18 Aug 2010
Links to Result pages
 
1